Vanta Bioscience Limited (VANTABIO.BO)
INR 42.57
(0.0%)
INR 42.57
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 488.01 Million INR | 3.69% |
| 2022 | 470.66 Million INR | 27.22% |
| 2021 | 369.97 Million INR | 32.91% |
| 2020 | 278.36 Million INR | 103.91% |
| 2019 | 136.51 Million INR | 12.21% |
| 2018 | 121.66 Million INR | 21.91% |
| 2017 | 99.8 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q4 | 488.01 Million INR | 6.11% |
| 2023 FY | 488.01 Million INR | 3.69% |
| 2023 Q2 | 459.9 Million INR | -2.29% |
| 2022 Q4 | 470.66 Million INR | 30.66% |
| 2022 Q2 | 360.23 Million INR | -2.63% |
| 2022 FY | 470.66 Million INR | 27.22% |
| 2021 FY | 369.97 Million INR | 32.91% |
| 2021 Q2 | 325.02 Million INR | 16.76% |
| 2021 Q4 | 369.97 Million INR | 13.83% |
| 2020 Q2 | 202.46 Million INR | 48.31% |
| 2020 FY | 278.36 Million INR | 103.91% |
| 2020 Q4 | 278.36 Million INR | 37.48% |
| 2019 Q4 | 136.51 Million INR | 18.92% |
| 2019 FY | 136.51 Million INR | 12.21% |
| 2019 Q2 | 114.79 Million INR | -5.65% |
| 2018 FY | 121.66 Million INR | 21.91% |
| 2018 Q4 | 121.66 Million INR | 10.21% |
| 2018 Q2 | 110.39 Million INR | 10.61% |
| 2017 FY | 99.8 Million INR | 0.0% |
| 2017 Q4 | 99.8 Million INR | 23.85% |
| 2017 Q2 | 80.57 Million INR | 7.44% |
| 2016 Q4 | 75 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alfavision Overseas (India) Limited | 1.35 Billion INR | 64.024% |
| Biocon Limited | 129.32 Billion INR | 99.623% |
| Blue Jet Healthcare Limited | 3.79 Million INR | -12776.359% |
| Concord Biotech Limited | 18.87 Million INR | -2486.19% |
| Dishman Carbogen Amcis Limited | 2.45 Billion INR | 80.131% |
| FERMENTA BIOTECH LIMITED | 425.36 Million INR | -14.73% |
| GENOMIC VALLEY BIOTECH LIMITED | - INR | -Infinity% |
| Lyka Labs Limited | 429.06 Million INR | -13.738% |
| Panacea Biotec Limited | 209.9 Million INR | -132.498% |
| SAMSRITA LABS LIMITED | - INR | -Infinity% |
| Servoteach Industries Limited | 5059.00 INR | -9646351.868% |
| SMS Lifesciences India Limited | 331.45 Million INR | -47.236% |
| Supriya Lifescience Limited | 50.2 Million INR | -872.139% |
| Syngene International Limited | 1 Billion INR | 51.199% |
| TAKE Solutions Limited | 7.5 Million INR | -6406.853% |
| Titan Biotech Limited | 4.53 Million INR | -10665.806% |
| Transgene Biotek Limited | 50.79 Million INR | -860.752% |